Assessing The Combined Impact of Blockchain, AI, And IoT on Operational Efficiency in Pharmaceutical Supply Chains: A Multi-Case Study Approach
No Thumbnail Available
Date
2025
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Saudi Digital Library
Abstract
This thematic study examines the integration of blockchain, artificial
intelligence (AI), and the Internet of Things (IoT) in transforming
pharmaceutical supply chains (PSCs) by enhancing their operational
efficiency and resilience, based on three case studies.
Aim:
This study aims to critically investigate how the integrated application of
these digital technologies promotes operational efficiency in PSCs. It
concentrates on the adoption patterns, performance metrics, and strategic
alignment of these integrated technologies with AstraZeneca, Pfizer, and
Johnson & Johnson as case studies.
Design:
This study has employed a qualitative multi-case study approach, using
secondary data sources encompassing peer-reviewed academic research
articles, industry reports, and company data. Thematic text analysis has
been carried out to identify patterns and extract insights systematically.
The analysis is grounded in three relevant theories: the Resource-Based
View (RBV), the Technology Acceptance Model (TAM), and the Supply Chain
Resilience (SCR). Guided by these theories, the study interprets strategic
resource management, technology adoption behaviours, and resilience
enhancement in PSCs.
Findings:
The integrated use of blockchain, AI, and IoT has created a cyber-physical
ecosystem in PSCs that enormously enhances practical visibility,
traceability, inventory optimisation, lead-time reduction, risk mitigation,
and regulatory compliance. These digital resources, in combination, have
fostered productivity and supply chain resilience, especially witnessed amid
the COVID-19 pandemic. Nevertheless, this integration also encounters
barriers encompassing technical issues in the form of interoperability,
cybersecurity, organisational hurdles in the form of required skills and
change resistance, and regulatory challenges in the form of data privacy
and complex compliance frameworks.
Originality:
This research is unique in that the present literature has gaps, and it fills
them with a focus on the integrated impact of the simultaneous adoption of
these technologies instead of adopting them in isolation, as other studies
have. This study scientifically validates integrated technology advantages
via three case studies, and hence, it offers real-time strategic and
managerial recommendations. This study also reveals the significant role of
harmonised policies and cross-sector coordination to overcome barriers
toward this technological integration, and hence it enriches academia,
besides the convergence of three digital technologies for resilient and
efficient PSCs.
Description
Keywords
Pharmaceutical companies, supply chain, AI, Blockchain, Internet of Things IoT, operational efficiency, technological integration, and combined technology application.
